logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

In-hospital safety in field conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. B. Gambiense Sleeping Sickness

Schmid C, Kuemmerle A, Blum J, Ghabri S, Kande V,  et al.
2012-11-29 • PLOS Neglected Tropical Diseases
2012-11-29 • PLOS Neglected Tropical Diseases
Trypanosoma brucei (T.b.) gambiense Human African trypanosomiasis (HAT; sleeping sickness) is a fatal disease. Until 2009, available treatments for 2(nd) stage HAT were complicated to us...
Journal Article
|
Research

Efficacy, Safety, and Dose of Pafuramidine, a New Oral Drug for Treatment of First Stage Sleeping Sickness, in a Phase 2a Clinical Study and Phase 2b Randomized Clinical Studies

Burri C, Yeramian PD, Allen JL, Merolle A, Serge KK,  et al.
2016-02-16 • PLOS Neglected Tropical Diseases
2016-02-16 • PLOS Neglected Tropical Diseases
BACKGROUND
Sleeping sickness (human African trypanosomiasis [HAT]) is caused by protozoan parasites and characterized by a chronic progressive course, which may last up to several ye...
Journal Article
|
Commentary

Human African trypanosomiasis

Brun R, Blum J, Chappuis F, Burri C
2009-10-14 • Lancet
2009-10-14 • Lancet
Human African trypanosomiasis (sleeping sickness) occurs in sub-Saharan Africa. It is caused by the protozoan parasite Trypanosoma brucei, transmitted by tsetse flies. Almost all cases a...
Journal Article
|
Commentary

Human African trypanosomiasis [review]

Brun R, Blum J, Chappuis F, Burri C
2010-01-09 • Lancet
2010-01-09 • Lancet